Last edition
News about Drug Discovery & Development
IIT Kanpur Scientists' Research Reveals How a Promising Vaccine Booster Switches on Immune Cells
IIT Kanpur scientists have uncovered how the vaccine booster candidate EP67 activates immune cells, paving the way for safer vaccines and immune therapies.
Drug Discovery & Development | 24/07/2026 | By News Bureau
New patient-derived xenograft study demonstrates strong synergy between GLIX1 and PARP inhibitors in HR-proficient ovarian cancer, paving the way for expanded clinical evaluation in Phase 1/2a trials.
Drug Discovery & Development | 09/07/2026 | By News Bureau
The rise of GLP-1 therapies has transformed diabetes and obesity treatment. Following semaglutide patent expiry in India in March 2026, multiple companies entered the market simultaneously. Pharma Industrial India spoke with industry leaders about the opportunities, challenges, and future of this rapidly evolving therapeutic segment.
Drug Discovery & Development | 26/06/2026 | By Akanki | 116
Simcere Pharmaceutical and Stanford Medicine Partner on IPF Therapy Research
Simcere Pharmaceutical has entered a research collaboration with Stanford Medicine to develop innovative therapies for Idiopathic Pulmonary Fibrosis (IPF).
Drug Discovery & Development | 16/06/2026 | By News Bureau
Pfizer and Innovent Biologics Partner to Advance Global Oncology Drug Development
Pfizer and Innovent Biologics have entered a global strategic collaboration to develop innovative oncology medicines, combining 12 discovery and early-stage programs to accelerate cancer drug development through shared research, clinical development, and commercialisation efforts.
Drug Discovery & Development | 29/05/2026 | By News Bureau | 124
The Lupus Research Alliance and Genentech announce inaugural recipients of the Immune Resetting Therapies for Lupus Award to accelerate research into CAR-T cell therapies for severe lupus patients.
Drug Discovery & Development | 28/05/2026 | By News Bureau | 147
Merz Therapeutics and Kvvit Sign China Deal for INBRIJA Parkinson's Therapy
Merz Therapeutics and Kvvit sign an exclusive agreement for commercialization of INBRIJA in mainland China, Hong Kong, and Macao, expanding access to advanced treatment options for Parkinson's disease patients.
Drug Discovery & Development | 26/05/2026 | By News Bureau | 169
Ichnos Glenmark Innovation Unveils Novel Multispecific Antibody Candidate for Solid Tumour Treatment
Ichnos Glenmark Innovation has introduced ISB 2301, a next-generation multispecific antibody designed to activate immune cells and target solid tumours through a multi-mechanism approach aimed at improving cancer treatment outcomes.
Drug Discovery & Development | 22/05/2026 | By News Bureau | 229
RFiD Discovery Deploys RFID Inventory Tracking System for Sanofi R&D Sites
RFiD Discovery has implemented a passive RFID inventory management system for Sanofi, enabling real-time tracking of critical research materials at its R&D facilities in France and the United States.
Drug Discovery & Development | 18/05/2026 | By News Bureau | 138
Researchers Discover First Human Antibody Panel Targeting Measles Virus
NIH-funded researchers identify the first suite of human antibodies targeting the measles virus, paving the way for new antibody-based treatments.
Drug Discovery & Development | 16/05/2026 | By News Bureau | 152
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy